These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9228240)

  • 21. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
    Carel JC; Blumberg J; Seymour C; Adamsbaum C; Lahlou N;
    Eur J Endocrinol; 2006 Jan; 154(1):119-24. PubMed ID: 16382000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature.
    Ökdemir D; Hatipoğlu N; Akar HH; Gül Ü; Akın L; Tahan F; Kurtoğlu S
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):923-5. PubMed ID: 25719301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
    Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC
    Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732
    [No Abstract]   [Full Text] [Related]  

  • 25. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J; Reynaud R; Czernichow P
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist.
    Yeshaya A; Kauschansky A; Orvieto R; Varsano I; Nussinovitch M; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):327-9. PubMed ID: 9539281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [True precocious puberty in girl. Therapy with LHRH analogs].
    Wasikowa R; Iwanicka Z; Pellar J; Hirowska I; Barg E
    Kinderarztl Prax; 1990 Jul; 58(7):335-40. PubMed ID: 2145459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension during therapy with triptorelin in a girl with precocious puberty.
    Calcaterra V; Mannarino S; Corana G; Codazzi AC; Mazzola A; Brambilla P; Larizza D
    Indian J Pediatr; 2013 Oct; 80(10):884-5. PubMed ID: 23180401
    [No Abstract]   [Full Text] [Related]  

  • 29. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
    Nunez SB; Calis K; Cutler GB; Jones J; Feuillan PP
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5730-3. PubMed ID: 14671160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results.
    Mul D; Bertelloni S; Carel JC; Saggese G; Chaussain JL; Oostdijk W
    Horm Res; 2002; 58(1):1-7. PubMed ID: 12169774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.
    Weise M; Flor A; Barnes KM; Cutler GB; Baron J
    J Clin Endocrinol Metab; 2004 Jan; 89(1):103-7. PubMed ID: 14715835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term experiences with a long-acting gonadotropin releasing hormone analog in therapy of central precocious puberty: effect on body growth].
    Hofmann-Ehrhart B; Schulz U; Kluge M; Wandl-Vergesslich K; Waldhauser F
    Wien Klin Wochenschr; 1995; 107(14):413-7. PubMed ID: 7668000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial male-limited precocious puberty (testotoxicosis): Usefulness of treatment with ketoconazole and triptorelin.
    García García E; Álvarez Del Vayo C; Castaño L
    Med Clin (Barc); 2022 Dec; 159(11):e79-e80. PubMed ID: 36049976
    [No Abstract]   [Full Text] [Related]  

  • 35. Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment.
    Arrigo T; De Luca F; Antoniazzi F; Galluzzi F; Iughetti L; Pasquino AM; Salerno MC; Marseglia L; Crisafulli G
    Eur J Pediatr; 2007 Jan; 166(1):73-4. PubMed ID: 16906400
    [No Abstract]   [Full Text] [Related]  

  • 36. Adult height in precocious puberty after long-term treatment with deslorelin.
    Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment.
    Salerno M; Di Maio S; Gasparini N; Mariano A; Macchia V; Tenore A
    Horm Res; 1998; 50(4):205-11. PubMed ID: 9838241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia.
    Hoogeveen J; Van der Veer E
    J Sex Med; 2008 Mar; 5(3):626-30. PubMed ID: 17971105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin releasing hormone agonist treatment for central precocious puberty.
    Carel JC; Chaussain JL
    Horm Res; 1999; 51 Suppl 3():64-9. PubMed ID: 10592446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From the National Institutes of Health.
    Wyngaarden JB
    JAMA; 1986 Sep; 256(9):1097. PubMed ID: 3525879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.